Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Webber

Showing results (351-360 of 408) with videos related to

Pageof 41
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 11, 1991
Relationship of tumor-cell ploidy to histologic subtype and treatment outcome in children and adolescents with unresectable rhabdomyosarcomaD N Shapiro, D M Parham, E C Douglass, et al.
Investigational New Drugs|March 14, 2024
A phase 1 trial of the MEK inhibitor selumetinib in combination with pembrolizumab for advanced or metastatic solid tumorsMaxime Chénard-Poirier, Aaron R Hansen, Martin E Gutierrez, et al.
Genomics|June 14, 2000
A high-resolution radiation hybrid map of the proximal portion of mouse chromosome 5L M Tarantino, L Feiner, A Alavizadeh, et al.
Experimental Neurology|February 7, 2018
Neuronal-specific impairment of heparan sulfate degradation in Drosophila reveals pathogenic mechanisms for Mucopolysaccharidosis type IIIADani L Webber, Amanda Choo, Laura J Hewson, et al.
Cancer|November 1, 1994
Agreement among and within groups of pathologists in the classification of rhabdomyosarcoma and related childhood sarcomas. Report of an international study of four pathology classificationsL Asmar, E A Gehan, W A Newton, et al.
Journal for Immunotherapy of Cancer|July 6, 2022
Baseline and post-treatment biomarkers of resistance to anti-PD-1 therapy in acral and mucosal melanoma: an observational studyIrene M Shui, Xiao Qiao Liu, Qing Zhao, et al.
Investigational New Drugs|April 11, 2023
Results of an open-label phase 1b study of the ERK inhibitor MK-8353 plus the MEK inhibitor selumetinib in patients with advanced or metastatic solid tumorsAnastasios Stathis, Anthony W Tolcher, Judy S Wang, et al.
Preventive Medicine|July 1, 1996
The effects of the Child and Adolescent Trial for Cardiovascular Health upon psychosocial determinants of diet and physical activity behaviorE Edmundson, G S Parcel, H A Feldman, et al.
Cancer|September 15, 1995
Classification of rhabdomyosarcomas and related sarcomas. Pathologic aspects and proposal for a new classification--an Intergroup Rhabdomyosarcoma StudyW A Newton, E A Gehan, B L Webber, et al.
Developmental Medicine and Child Neurology|June 17, 2020
Definition and diagnosis of cerebral palsy in genetic studies: a systematic reviewRyan Pham, Ben W Mol, Jozef Gecz, et al.
Pageof 41

Showing results (351-360 of 408) with videos related to

Sort By:
Pageof 41
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 11, 1991
Relationship of tumor-cell ploidy to histologic subtype and treatment outcome in children and adolescents with unresectable rhabdomyosarcomaD N Shapiro, D M Parham, E C Douglass, et al.
Investigational New Drugs|March 14, 2024
A phase 1 trial of the MEK inhibitor selumetinib in combination with pembrolizumab for advanced or metastatic solid tumorsMaxime Chénard-Poirier, Aaron R Hansen, Martin E Gutierrez, et al.
Genomics|June 14, 2000
A high-resolution radiation hybrid map of the proximal portion of mouse chromosome 5L M Tarantino, L Feiner, A Alavizadeh, et al.
Experimental Neurology|February 7, 2018
Neuronal-specific impairment of heparan sulfate degradation in Drosophila reveals pathogenic mechanisms for Mucopolysaccharidosis type IIIADani L Webber, Amanda Choo, Laura J Hewson, et al.
Cancer|November 1, 1994
Agreement among and within groups of pathologists in the classification of rhabdomyosarcoma and related childhood sarcomas. Report of an international study of four pathology classificationsL Asmar, E A Gehan, W A Newton, et al.
Journal for Immunotherapy of Cancer|July 6, 2022
Baseline and post-treatment biomarkers of resistance to anti-PD-1 therapy in acral and mucosal melanoma: an observational studyIrene M Shui, Xiao Qiao Liu, Qing Zhao, et al.
Investigational New Drugs|April 11, 2023
Results of an open-label phase 1b study of the ERK inhibitor MK-8353 plus the MEK inhibitor selumetinib in patients with advanced or metastatic solid tumorsAnastasios Stathis, Anthony W Tolcher, Judy S Wang, et al.
Preventive Medicine|July 1, 1996
The effects of the Child and Adolescent Trial for Cardiovascular Health upon psychosocial determinants of diet and physical activity behaviorE Edmundson, G S Parcel, H A Feldman, et al.
Cancer|September 15, 1995
Classification of rhabdomyosarcomas and related sarcomas. Pathologic aspects and proposal for a new classification--an Intergroup Rhabdomyosarcoma StudyW A Newton, E A Gehan, B L Webber, et al.
Developmental Medicine and Child Neurology|June 17, 2020
Definition and diagnosis of cerebral palsy in genetic studies: a systematic reviewRyan Pham, Ben W Mol, Jozef Gecz, et al.
Pageof 41